Memphasys Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.

Q: Is Memphasys Ltd overvalued?

According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: How many shares outstanding does Memphasys Ltd have?

Memphasys Ltd has 1,771,014,800 shares outstanding.

Q: What happened to Memphasys Ltd’s price movement after its last earnings report?

Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

6 Followers

MEM Stock Chart & Stats

Advanced Chart >

Day’s Range― - ―

52-Week Range<AU$0.01 - AU$0.01

Previous CloseN/A

Volume7.30M

Average Volume (3M)4.91M

Market Cap

AU$14.17M

Enterprise ValueAU$14.21M

Total Cash (Recent Filing)$3.83M

Total Debt (Recent Filing)$1.02M

Price to Earnings (P/E)―

Beta-0.63

Next Earnings

Feb 21, 2025

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding1,771,014,800

10 Day Avg. Volume5,158,627

30 Day Avg. Volume4,911,412

Standard Deviation0.23

R-Squared0.06

Alpha-0.01

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)972.50

Price to Cash Flow (P/CF)N/A

P/FCF Ratio0.00

Enterprise Value/Market Cap1.00

Enterprise Value/RevenueN/A

Enterprise Value/Gross Profit1.72K

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

Memphasys Ltd News

PremiumCompany Announcements

Memphasys Unveils Diagnostic Breakthrough with RoXsta™ System

4d ago

PremiumCompany Announcements

Memphasys Ltd Issues New Top Up Options

1M ago

PremiumCompany Announcements

Memphasys Ltd to Quote New Shares on ASX

1M ago

PremiumCompany Announcements

Memphasys Ltd Advances with Felix™ System Study Completion

1M ago

PremiumCompany Announcements

Memphasys Ltd Expands with Dubai Felix™ System Order

2M ago

PremiumCompany Announcements

Memphasys Ltd Announces Board Changes and New Offer

2M ago

PremiumCompany Announcements

Memphasys Ltd Announces Director Resignation

2M ago

PremiumCompany Announcements

Memphasys Ltd Reports Positive AGM Outcomes

2M ago

See More AU:MEM News >

Financials

Annual

Income Statement >

MEM FAQ

What was Memphasys Ltd’s price range in the past 12 months?

Memphasys Ltd lowest share price was <AU$0.01 and its highest was AU$0.01 in the past 12 months.

What is Memphasys Ltd’s market cap?

Memphasys Ltd’s market cap is AU$14.17M.

When is Memphasys Ltd’s upcoming earnings report date?

Memphasys Ltd’s upcoming earnings report date is Feb 21, 2025 which is in 33 days.

How were Memphasys Ltd’s earnings last quarter?

Memphasys Ltd released its earnings results on Aug 30, 2024. The company reported -AU$0.002 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.002.

Is Memphasys Ltd overvalued?

According to Wall Street analysts Memphasys Ltd’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Memphasys Ltd pay dividends?

Memphasys Ltd does not currently pay dividends.

What is Memphasys Ltd’s EPS estimate?

Memphasys Ltd’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Memphasys Ltd have?

Memphasys Ltd has 1,771,014,800 shares outstanding.

What happened to Memphasys Ltd’s price movement after its last earnings report?

Memphasys Ltd reported an EPS of -AU$0.002 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Memphasys Ltd?

Currently, no hedge funds are holding shares in AU:MEM

---

Memphasys Ltd Stock Smart Score

Unlock Smart Score

Fundamentals

Return on Equity

-62.46%

Trailing 12-Months

Asset Growth

-15.26%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Memphasys Ltd

Memphasys Ltd operates as a bio-separations company in Australia. It is engaged in developing and commercializing separation techniques based on the company's proprietary membrane technology. Its technology includes Hydrogel and other polymer membrane technology development. The company is developing novel medical devices, diagnostics, and media with applications to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

---

Similar Stocks

AVE

Avecho Biotechnology Limited

―

RAC

Race Oncology Ltd.

―

CC5

LBT Innovations Limited

―

PCK